DOX Amdocs Ltd

Amdocs Ltd. (DOX), FMC Corp. (FMC), and TC Energy Corp (TRP) are slated to trade ex-dividend on December 31, 2025. Investors should anticipate slight drops in their stock prices reflecting the dividend payouts of $0.527, $0.08, and $0.85 per share respectively. Based on current stock prices, the estimated annualized yields are 2.58% for Amdocs, 2.36% for FMC, and 6.09% for TC Energy.

Amdocs (NASDAQ:DOX) experienced unusually large options trading, with traders purchasing 3,620 call options, a 1,747% increase over typical volume, indicating strong bullish interest. The company declared a quarterly dividend of $0.527 per share, yielding approximately 2.6% with an ex-dividend date of December 31. Amdocs currently trades at $80.08, has a market capitalization of $8.64 billion, and analysts hold a "Moderate Buy" consensus with an average price target of $97.

This article reviews the Q3 earnings season for IT services and tech stocks, focusing on Amdocs (NASDAQ:DOX) and its peers. Amdocs reported revenues of $1.15 billion, exceeding expectations despite a mixed quarter. The article also touches on other companies like Applied Digital, Grid Dynamics, Diebold Nixdorf, and Hewlett Packard Enterprise, highlighting their Q3 performance and market reactions.

Amdocs Limited (NASDAQ: DOX) has scheduled its annual general meeting for January 30, 2026, where shareholders will vote on key proposals including the election of 10 directors, an amendment to increase the Employee Share Purchase Plan (ESPP) share reserve by 2.2 million shares, and a quarterly cash dividend increase from $0.527 to $0.569 per share. The company also seeks approval for its fiscal 2025 financial statements and the re-appointment of Ernst & Young LLP as its independent auditor for fiscal 2026. This meeting reflects Amdocs' consistent focus on shareholder returns and employee ownership.

Amdocs recently concluded FY 2025 with $1.2 billion in Q4 revenue and $0.88 EPS, showcasing a shift towards profitability over top-line growth, with net profit margin improving to 12.5%. While EPS rebounded by 14.5% year-over-year, its five-year trend remains negative, leading to differing bullish and bearish valuation perspectives. The company trades at a P/E of 15.2x, below peers, with a DCF fair value significantly higher than its current share price, yet slower forecast growth and client concentration raise concerns.

Zacks Research has lowered its Q1 2026 EPS estimate for Amdocs to $1.54, significantly below the company's own guidance of $1.73–$1.79. Despite this, analyst sentiment remains mixed, with a consensus of "Moderate Buy" and an average price target of $97. Amdocs recently exceeded its quarterly EPS expectations and declared a quarterly dividend of $0.527.